Celltech's path to acquisition Selected events traced against the weekly stock price of Celltech (LSE:CCH; CLL) in pence over the past five years. A.6/15/99Chiroscience merger announced; CCH 6/14/99 Mcap = £364.8M ($591M)B.8/6/99Chiroscience merger completedC.11/11/99Medeva acquisition...

Researchers published in Nature Biotechnology the use of a bacterial erythromycin-resistance regulon to design an inducible mammalian gene regulation system that is responsive to erythromycin, clarithromycin, and roxithromycin. The researchers validated this technology by controlling...

UCLA researchers published in Nature Medicine the development of a reporter system to image gene expression in vivo for use in monitoring gene therapy treatments. In the reporter system, a common promoter directs expression of...